Register Menu Close
Headshot

Carla Cartwright

Head Global Digital and Regulatory Policy Johnson & Johnson

Carla leads global digital, R&D, and regulatory policy for Johnson & Johnson’s Government Affairs & Policy (GA&P) policy team across the pharmaceutical and medical device sectors. She drives work on a variety of policy issues including AI and data ethics, health equity, and regulatory modernization and represents GA&P in several internal and external fora including the Johnson & Johnson Data Science and Data Management Councils.

Prior to joining Johnson & Johnson, Carla was an attorney and team leader in FDA’s Office of the Chief Counsel where she advised the Center for Drug Evaluation and Research on legal and policy issues. Living in Kensington MD with her spouse and seventeen-year-old son, Carla enjoys traveling, baking, trying to keep her many plants alive, and book clubs. She serves on the board of the Educational Foundation for her son’s school. Carla is a graduate of Washington University in St. Louis and has a JD from Yale Law School and an LLM from Georgetown University Law Center.

See Carla Cartwright at this event

  • Day 3 Thursday 5 December

E-labelling as a pathway to a future Universal Label

07:30 - 09:00 CET / 17:30 - 19:00 AEDT

Session objectives:

  • Share the experience of adopting e-labelling, and opportunities for further harmonization and better interoperability.
  • Open a dialogue on the concept of universal labelling, in the context of an evolving digital healthcare ecosystem highlighting its potential to streamline supply chain logistics, reduce packaging waste, and support a green economy.
  • Examine how these systems may alleviate drug shortages, enhance preparedness for future pandemics, and expedite manufacturing processes.
  • By initiating this vital conversation now, the session seeks to align direction around future digital labelling options.

Speakers